# MDMA-Assisted Therapy for Mental Healthcare Providers

> **NCT07102576** · PHASE1 · RECRUITING · sponsor: **Rachel Yehuda** · enrollment: 30 (estimated)

## Conditions studied

- Mental Wellbeing

## Interventions

- **DRUG:** MDMA Hydrochloride

## Key facts

- **NCT ID:** NCT07102576
- **Lead sponsor:** Rachel Yehuda
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-11
- **Primary completion:** 2029-09-21
- **Final completion:** 2029-12-21
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07102576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07102576, "MDMA-Assisted Therapy for Mental Healthcare Providers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07102576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*